Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer

Ana Bocanegra, Gonzalo Fernández, Daniel Ajona, Hugo Arasanz, Ester Blanco, Miren Zuazo, Luisa Chocarro, Sergio Piñeiro-Hermida, Pilar Morente, Leticia Fernández, Maider Garnica, Ana Remirez, Maite Martinez-Aguillo, Idoia Morilla, Beatriz Tavira, Pablo Ramos, Miriam Echaide, Juan José Lasarte, Luis Montuenga, Ruth Vera, Ruben Pio, David Escors, Grazyna Kochan
doi: https://doi.org/10.1101/2022.06.16.22276511

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted June 21, 2022.
Download PDF
Data/Code
Email
Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer
Ana Bocanegra, Gonzalo Fernández, Daniel Ajona, Hugo Arasanz, Ester Blanco, Miren Zuazo, Luisa Chocarro, Sergio Piñeiro-Hermida, Pilar Morente, Leticia Fernández, Maider Garnica, Ana Remirez, Maite Martinez-Aguillo, Idoia Morilla, Beatriz Tavira, Pablo Ramos, Miriam Echaide, Juan José Lasarte, Luis Montuenga, Ruth Vera, Ruben Pio, David Escors, Grazyna Kochan
medRxiv 2022.06.16.22276511; doi: https://doi.org/10.1101/2022.06.16.22276511
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area